Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York
REHOVOT, Israel, Aug. 28, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology and chemistry company,...
Pharmaceutical
SmartLabs and Sonrai Launch Exclusive Partnership to Bring Advanced AI Capabilities to SmartLabs’ Member Companies
Strategic Partnership Agreement Integrates Sonrai's AI Data Management Platform, Sonrai Discovery, with SmartLabs' Advanced Laboratory Infrastructure BOSTON, Aug. 28, 2025 /PRNewswire/ -- SmartLabs and...
CASI Pharmaceuticals to Participate at Cantor Global Healthcare Conference 2025
SAN FRANCISCO, CA / ACCESS Newswire / August 28, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused...
Phase 1 Equity Announces It’s Sixth Practice Addition Of The Year, Bringing On A Multi-Site, Multi-Doctor Orthodontic Practice Located in Ohio
CHICAGO, IL / ACCESS Newswire / August 28, 2025 / Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for...
Black Book Research Unveils First Pan-European Study of EHDS Interoperability Vendors as Hospitals Brace for 2026 Compliance Deadline
Independent Benchmarking Across 13 EU Countries and the UK Reveals Vendor Readiness and Country Gaps Ahead of EHDS Enforcement LONDON,...
Telomir Pharmaceuticals Reports In Vitro Data Supporting the Potential of Telomir-1 as a First-in-Class Epigenetic Therapy Influencing DNA Methylation Pathways in Cancer, Aging, and Age-Related Diseases
In vitro findings reveal Telomir-1's dual action: targeting DNA methylation switches and cutting into the Wnt "fuel line" that drives...
UniDoc Health Corp. Provides Corporate Update
VANCOUVER, BC / ACCESS Newswire / August 28, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or "the Company") pleased to...
Can-Fite Reports H1 2025 Financial Results and Clinical Update
Ramat Gan, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company...
CorMedix to Participate in Upcoming Investor Conferences
BERKELEY HEIGHTS, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (“CorMedix”) (Nasdaq: CRMD), a biopharmaceutical company focused on developing...
Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference
DOYLESTOWN, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company...
Moleculin Announces Exercise of Warrants for $6.0 Million Gross Proceeds
HOUSTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company...
Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss
Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in...
Candel Therapeutics to Participate in Upcoming Investor Conferences in September
NEEDHAM, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical...
Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESS Newswire / August 28, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters,...
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2
CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and...
XtalPi Holdings Announces 2025 Interim Results
SHENZHEN, China, Aug. 27, 2025 /PRNewswire/ -- Key Highlights from the Financial Report: Revenue surged 404% year over year to...
Hot Melt Extrusion: Accelerating Drug Development for Poorly Soluble APIs, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain an overview of common formulation challenges in global pharmaceutical development, particularly for APIs with poor...
Analytical Platform for Rapid, Reliable mRNA Modality Analytics, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insight into rapid, reliable analytics for evolving mRNA modalities. Attendees will learn about mRNA modality-specific CQA...
Oracle Enhances Electronic Data Capture Solution to Streamline Clinical Trials and Help Bring New Therapies to Market Faster
Updates include AI-enabled EHR interoperability, comprehensive data collection, and safety integration capabilities AUSTIN, Texas, Aug. 27, 2025 /PRNewswire/ -- Oracle today...
Glidewell Unveils GlidePRO(TM): A Restorative-Driven, Fully Guided Solution for Full-Arch Implant Cases
New GlidePRO™ offers crown-down planning, personalized support and same-day provisionalization to support All-on-X procedures. IRVINE, CALIFORNIA / ACCESS Newswire /...